位置:首页 > 蛋白库 > GUC1A_BOVIN
GUC1A_BOVIN
ID   GUC1A_BOVIN             Reviewed;         205 AA.
AC   P46065;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   03-AUG-2022, entry version 161.
DE   RecName: Full=Guanylyl cyclase-activating protein 1;
DE            Short=GCAP 1;
DE   AltName: Full=Guanylate cyclase activator 1A;
GN   Name=GUCA1A; Synonyms=GCAP1, GUCA1;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PARTIAL PROTEIN SEQUENCE, FUNCTION,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, IDENTIFICATION BY MASS
RP   SPECTROMETRY, CALCIUM-BINDING, AND MYRISTOYLATION AT GLY-2.
RC   TISSUE=Retina;
RX   PubMed=7520254; DOI=10.1016/0896-6273(94)90355-7;
RA   Palczewski K., Subbaraya I., Gorczyca W.A., Helekar B.S., Ruiz C.C.,
RA   Ohguro H., Huang J., Zhao X., Crabb J.W., Johnson R.S., Walsh K.A.,
RA   Gray-Keller M.P., Detwiler P.B., Baehr W.;
RT   "Molecular cloning and characterization of retinal photoreceptor guanylyl
RT   cyclase-activating protein.";
RL   Neuron 13:395-404(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=8626484; DOI=10.1074/jbc.271.14.8022;
RA   Frins S., Boenigk W., Mueller F., Kellner R., Koch K.W.;
RT   "Functional characterization of a guanylyl cyclase-activating protein from
RT   vertebrate rods. Cloning, heterologous expression, and localization.";
RL   J. Biol. Chem. 271:8022-8027(1996).
RN   [3]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=9620085;
RA   Cuenca N., Lopez S., Howes K., Kolb H.;
RT   "The localization of guanylyl cyclase-activating proteins in the mammalian
RT   retina.";
RL   Invest. Ophthalmol. Vis. Sci. 39:1243-1250(1998).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=10821676; DOI=10.1021/bi9929960;
RA   Venkataraman V., Nagele R., Duda T., Sharma R.K.;
RT   "Rod outer segment membrane guanylate cyclase type 1-linked stimulatory and
RT   inhibitory calcium signaling systems in the pineal gland: biochemical,
RT   molecular, and immunohistochemical evidence.";
RL   Biochemistry 39:6042-6052(2000).
RN   [5]
RP   FUNCTION, AND MUTAGENESIS OF TYR-99.
RX   PubMed=9651312; DOI=10.1074/jbc.273.28.17311;
RA   Dizhoor A.M., Boikov S.G., Olshevskaya E.V.;
RT   "Constitutive activation of photoreceptor guanylate cyclase by Y99C mutant
RT   of GCAP-1. Possible role in causing human autosomal dominant cone
RT   degeneration.";
RL   J. Biol. Chem. 273:17311-17314(1998).
RN   [6]
RP   STRUCTURE BY NMR OF 2-205, CALCIUM-BINDING, FUNCTION, DOMAIN, AND
RP   MUTAGENESIS OF VAL-77; ARG-172; SER-173 AND LEU-174.
RX   PubMed=26703466; DOI=10.1074/jbc.m115.696161;
RA   Lim S., Peshenko I.V., Olshevskaya E.V., Dizhoor A.M., Ames J.B.;
RT   "Structure of guanylyl cyclase activator protein 1 (GCAP1) mutant V77E in a
RT   Ca2+-free/Mg2+-bound activator state.";
RL   J. Biol. Chem. 291:4429-4441(2016).
CC   -!- FUNCTION: Stimulates retinal guanylyl cyclase when free calcium ions
CC       concentration is low and inhibits guanylyl cyclase when free calcium
CC       ions concentration is elevated (PubMed:7520254, PubMed:8626484,
CC       PubMed:9651312, PubMed:26703466). This Ca(2+)-sensitive regulation of
CC       retinal guanylyl cyclase is a key event in recovery of the dark state
CC       of rod photoreceptors following light exposure (PubMed:7520254,
CC       PubMed:8626484). May be involved in cone photoreceptor light response
CC       and recovery of response in bright light (By similarity).
CC       {ECO:0000250|UniProtKB:P43081, ECO:0000269|PubMed:7520254,
CC       ECO:0000269|PubMed:8626484}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:P43080}.
CC   -!- INTERACTION:
CC       P46065; P55203: GUCY2D; NbExp=2; IntAct=EBI-6943108, EBI-6943076;
CC       P46065; P81948: TUBA4A; NbExp=2; IntAct=EBI-6943108, EBI-6943159;
CC   -!- SUBCELLULAR LOCATION: Membrane; Lipid-anchor
CC       {ECO:0000269|PubMed:7520254}. Photoreceptor inner segment
CC       {ECO:0000269|PubMed:9620085}. Cell projection, cilium, photoreceptor
CC       outer segment {ECO:0000269|PubMed:9620085}. Note=Subcellular location
CC       is not affected by light or dark conditions.
CC       {ECO:0000250|UniProtKB:P43081}.
CC   -!- TISSUE SPECIFICITY: Detected in the retina (PubMed:7520254). Detected
CC       in rod and cone photoreceptor cells (at protein level) (PubMed:8626484,
CC       PubMed:9620085). Also present in certain pinealocytes
CC       (PubMed:10821676). {ECO:0000269|PubMed:10821676,
CC       ECO:0000269|PubMed:7520254, ECO:0000269|PubMed:8626484,
CC       ECO:0000269|PubMed:9620085}.
CC   -!- DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) when calcium
CC       levels are high. Binds Mg(2+) when calcium levels are low.
CC       {ECO:0000269|PubMed:26703466}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S74247; AAB31698.2; -; Genomic_DNA.
DR   EMBL; X95352; CAA64642.1; -; mRNA.
DR   RefSeq; NP_776971.1; NM_174546.2.
DR   PDB; 2NA0; NMR; -; A=2-205.
DR   PDBsum; 2NA0; -.
DR   AlphaFoldDB; P46065; -.
DR   BMRB; P46065; -.
DR   SMR; P46065; -.
DR   IntAct; P46065; 2.
DR   MINT; P46065; -.
DR   STRING; 9913.ENSBTAP00000017036; -.
DR   iPTMnet; P46065; -.
DR   PaxDb; P46065; -.
DR   PRIDE; P46065; -.
DR   Ensembl; ENSBTAT00000087322; ENSBTAP00000057125; ENSBTAG00000051956.
DR   GeneID; 282243; -.
DR   KEGG; bta:282243; -.
DR   CTD; 2978; -.
DR   VEuPathDB; HostDB:ENSBTAG00000051956; -.
DR   VGNC; VGNC:29714; GUCA1A.
DR   eggNOG; KOG0044; Eukaryota.
DR   GeneTree; ENSGT00940000160607; -.
DR   HOGENOM; CLU_072366_4_1_1; -.
DR   InParanoid; P46065; -.
DR   OMA; IRTINPC; -.
DR   OrthoDB; 1271942at2759; -.
DR   TreeFam; TF333971; -.
DR   Reactome; R-BTA-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Proteomes; UP000009136; Chromosome 23.
DR   Bgee; ENSBTAG00000051956; Expressed in retina and 43 other tissues.
DR   GO; GO:0120199; C:cone photoreceptor outer segment; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0001917; C:photoreceptor inner segment; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0008048; F:calcium sensitive guanylate cyclase activator activity; IDA:UniProtKB.
DR   GO; GO:0030249; F:guanylate cyclase regulator activity; IDA:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB.
DR   GO; GO:0007602; P:phototransduction; ISS:AgBase.
DR   GO; GO:0031284; P:positive regulation of guanylate cyclase activity; IDA:UniProtKB.
DR   GO; GO:0031282; P:regulation of guanylate cyclase activity; ISS:AgBase.
DR   GO; GO:0007601; P:visual perception; ISS:AgBase.
DR   CDD; cd00051; EFh; 2.
DR   DisProt; DP00840; -.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR033022; GUCA1A.
DR   InterPro; IPR028846; Recoverin.
DR   PANTHER; PTHR23055; PTHR23055; 1.
DR   PANTHER; PTHR23055:SF13; PTHR23055:SF13; 1.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   Pfam; PF13833; EF-hand_8; 1.
DR   SMART; SM00054; EFh; 3.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 3.
DR   PROSITE; PS50222; EF_HAND_2; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cell projection; Direct protein sequencing;
KW   Lipoprotein; Membrane; Metal-binding; Myristate; Reference proteome;
KW   Repeat; Sensory transduction; Vision.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000255"
FT   CHAIN           2..205
FT                   /note="Guanylyl cyclase-activating protein 1"
FT                   /id="PRO_0000073802"
FT   DOMAIN          14..49
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   DOMAIN          51..86
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   DOMAIN          87..122
FT                   /note="EF-hand 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   DOMAIN          131..166
FT                   /note="EF-hand 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   REGION          185..205
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         64
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   BINDING         66
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   BINDING         68
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   BINDING         70
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   BINDING         75
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   BINDING         100
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   BINDING         102
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   BINDING         104
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   BINDING         106
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   BINDING         111
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   BINDING         144
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   BINDING         146
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   BINDING         148
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   BINDING         150
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   BINDING         155
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0000269|PubMed:26703466"
FT   MOD_RES         3
FT                   /note="Deamidated asparagine"
FT                   /evidence="ECO:0000255"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:7520254"
FT   MUTAGEN         77
FT                   /note="V->E: Decreases affinity for calcium and promotes
FT                   magnesium binding at EF-hand 2."
FT                   /evidence="ECO:0000269|PubMed:26703466"
FT   MUTAGEN         99
FT                   /note="Y->C: Constitutively activates GUCY2D."
FT                   /evidence="ECO:0000269|PubMed:9651312"
FT   MUTAGEN         172
FT                   /note="Missing: Nearly abolishes activation of GUCY2D."
FT                   /evidence="ECO:0000269|PubMed:26703466"
FT   MUTAGEN         173
FT                   /note="S->SG: Abolishes activation of GUCY2D."
FT                   /evidence="ECO:0000269|PubMed:26703466"
FT   MUTAGEN         173
FT                   /note="Missing: Nearly abolishes activation of GUCY2D."
FT                   /evidence="ECO:0000269|PubMed:26703466"
FT   MUTAGEN         174
FT                   /note="Missing: Nearly abolishes activation of GUCY2D."
FT                   /evidence="ECO:0000269|PubMed:26703466"
FT   CONFLICT        108
FT                   /note="D -> I (in Ref. 1; AAB31698)"
FT                   /evidence="ECO:0000305"
FT   HELIX           8..14
FT                   /evidence="ECO:0007829|PDB:2NA0"
FT   HELIX           17..28
FT                   /evidence="ECO:0007829|PDB:2NA0"
FT   STRAND          31..35
FT                   /evidence="ECO:0007829|PDB:2NA0"
FT   HELIX           36..43
FT                   /evidence="ECO:0007829|PDB:2NA0"
FT   HELIX           51..64
FT                   /evidence="ECO:0007829|PDB:2NA0"
FT   STRAND          69..72
FT                   /evidence="ECO:0007829|PDB:2NA0"
FT   HELIX           73..83
FT                   /evidence="ECO:0007829|PDB:2NA0"
FT   HELIX           88..99
FT                   /evidence="ECO:0007829|PDB:2NA0"
FT   STRAND          103..105
FT                   /evidence="ECO:0007829|PDB:2NA0"
FT   HELIX           109..119
FT                   /evidence="ECO:0007829|PDB:2NA0"
FT   STRAND          124..130
FT                   /evidence="ECO:0007829|PDB:2NA0"
FT   HELIX           133..143
FT                   /evidence="ECO:0007829|PDB:2NA0"
FT   HELIX           144..146
FT                   /evidence="ECO:0007829|PDB:2NA0"
FT   HELIX           154..161
FT                   /evidence="ECO:0007829|PDB:2NA0"
FT   HELIX           164..173
FT                   /evidence="ECO:0007829|PDB:2NA0"
FT   HELIX           179..184
FT                   /evidence="ECO:0007829|PDB:2NA0"
SQ   SEQUENCE   205 AA;  23510 MW;  027B54ADB79EC0E1 CRC64;
     MGNIMDGKSV EELSSTECHQ WYKKFMTECP SGQLTLYEFR QFFGLKNLSP WASQYVEQMF
     ETFDFNKDGY IDFMEYVAAL SLVLKGKVEQ KLRWYFKLYD VDGNGCIDRD ELLTIIRAIR
     AINPCSDSTM TAEEFTDTVF SKIDVNGDGE LSLEEFMEGV QKDQMLLDTL TRSLDLTRIV
     RRLQNGEQDE EGASGRETEA AEADG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024